GlaxoSmithKline will ax 6,000 more jobs. The move has been expected for some time (See BNET’s note on Nov. 4.) But not everyone will be losing their jobs at GSK. Here’s a look at who’s career won’t be ruined by the coming round of cuts; followed by a brief note on what to expect in GSK’s upcoming Q4 earnings announcement. Media mogul Rupert* James Murdoch got a...
Pharma Industry Archive
February 2009
Welcome to February. It’s time for our traditional look back at the strangest stories that popped up onto last month’s radar: Race discrimination suit at Wyeth is all Morgan Freeman’s fault The Wyeth supervisor who triggered a discrimination suit because she allegedly described herself as “the head n—— in charge” says that she got the phrase from the...
- Novartis Looks at Combination Pills to Fix Hypertension Franchise
- Study Showing Drug Ads Are Linked to Higher Prices Has Flaws
- Bankers Reveal Top Biotech IPO Contenders; New Filer Ironwood Among Them
- Pfizer Got $160M in Tax Money to Build in Connecticut
- Sanofi's Viehbacher Backs Health Reform; May Change Company's Name
- Viagra Now Available Intravenously
- Genzyme Kidney Drug Failed, Too...What Could Possibly Happen Next?
- Peter Pitts' CMPI Targeted Over Anti-Healthcare Reform Video Game
- Why Allergan and Medicis Should Embrace the "Botox Tax" in Senate Health Bill
- Why J&J's Stelara Launch Should Target Dermatologists First
- NHS Loses Fight Over Publication of Antipsychotic Meds Brochures for Kids
- Genzyme's Termeer Got $50M in Compensation Over Last 3 Years; Wife Got Trips to Asia on Corporate Jet
- Merck Gives Snapshot of Combined Company: $47B in Sales; Just $7.6B in Cash
- Why Pfizer Wants Your Car-Sick Dog to Travel on Thanksgiving
- FDA Delays Genzyme's Lumizyme, Manufacturing Problems Blamed
- Will FDA Approve MannKind's Insulin Inhaler?
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted
- Hepatitis C Drugs Kill the Virus...and Your Sex Drive
- Microchip Implant to Link Your Health Records, Credit History, Social Security
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
- NYT's MannKind Story Needlessly Quoted a Competitor Bashing Afresa
- Novartis CEO Sends Emails to 140 Animal Rights Activists:
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low
Subscribe to Pharma blog comments RSS 
- How NOT to Write a Biotech Press Release: Just Ask Epeius
- The 10 Weirdest Drug Stories of the Month
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity"
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
Industry Transcripts by Seeking Alpha
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Archives
Recommended Sources
About Pharma Industry
BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.